Scientists Pioneer 3-D-Printed Drug Delivering Micro-Needles

Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery. The technique would offer a pain-free drug delivery device that would allow drugs to diffuse within the body as the biomaterial device degrades in the body. This offers treatments for a wide range of diseases, including melanoma cancers.

The results were published Wednesday 30th September, in the journal Biofabrication.

The researchers, based at the University of Akron, USA, and the University of Texas, USA, report producing a drug-loaded array for transdermal delivery of a chemotherapeutic drug, fabricated using microstereolithography. The arrays consisted of 25 poly(propylene fumarate) microneedles, each needle having a tip and base diameter of 20 µm and 200 µm, respectively, and a height of 1 mm.

Constructing the array was challenging, says Jae-Won Choi, an author on the paper.

"3D printing this array was difficult, as the printable biomaterial contains some non-printable solvents and drugs."

Dacarbazine, commonly used to treat skin cancer, was blended into the solution prior to crosslinking (a final part of the 3D printing process).

The needles were then tested and shown to be able to withstand the stresses and strains they would likely be submitted to when inserted into the body.

Drug-release profiles remain a challenge for the future, concedes Choi.

"We'd like to have a faster drug release, but this will require more material research. Once we improve this process we can look at developing more controlled drug release."

"I'd hope we'll see this being used clinically in 5-10 years" Choi concludes.

Biofabrication

Biofabrication focuses on research using cells, proteins, biomaterials and/or other bioactive elements as building blocks to fabricate advanced biological models, medical therapeutic products and non-medical biological systems.

IOP Publishing

IOP Publishing provides publications through which leading-edge scientific research is distributed worldwide.

Beyond our traditional journals programme, we make high-value scientific information easily accessible through an ever-evolving portfolio of books, community websites, magazines, conference proceedings and a multitude of electronic services.

IOP Publishing is central to the Institute of Physics, a not-for-profit society. Any financial surplus earned by IOP Publishing goes to support science through the activities of the Institute.

The Institute of Physics

The Institute of Physics is a leading scientific society. We are a charitable organisation with a worldwide membership of more than 50,000, working together to advance physics education, research and application.

We engage with policymakers and the general public to develop awareness and understanding of the value of physics and, through IOP Publishing, we are world leaders in professional scientific communications.